DLK2 抗体 (C-Term)
(1 reference)Quick Overview for DLK2 抗体 (C-Term) (ABIN2783902)
抗原
See all DLK2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
序列
- LVLPAPEPAS VGTPQMPTSA VVVPATGPAP HSAGAGLLRI SVKEVVRRQE
-
预测反应
- Cow: 93%, Dog: 86%, Guinea Pig: 86%, Horse: 86%, Human: 100%, Mouse: 100%, Pig: 93%, Rabbit: 93%, Rat: 93%
-
产品特性
- This is a rabbit polyclonal antibody against Dlk2. It was validated on Western Blot.
-
纯化方法
- Affinity Purified
-
免疫原
- The immunogen is a synthetic peptide directed towards the C-terminal region of Mouse Dlk2
-
-
anti-delta-Like 2 Homolog (DLK2) (AA 353-380), (C-Term) antibody
DLK2 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB23694 unconjugated
anti-delta-Like 2 Homolog (DLK2) (AA 353-380) antibodyDLK2 适用: 人 WB, ELISA, FACS, IHC 宿主: 兔 Polyclonal unconjugated
anti-delta-Like 2 Homolog (DLK2) (AA 1-383) antibodyDLK2 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-delta-Like 2 Homolog (DLK2) antibodyDLK2 适用: 人 WB, FACS, IHC 宿主: 兔 Polyclonal unconjugated
anti-delta-Like 2 Homolog (DLK2) (AA 27-305) antibodyDLK2 适用: 小鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-delta-Like 2 Homolog (DLK2) (AA 292-341) antibodyDLK2 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator.
-
说明
-
Antigen size: 425 AA
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice." in: Oncoimmunology, Vol. 6, Issue 3, pp. e1290035, (2017) (PubMed).
-
: "Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice." in: Oncoimmunology, Vol. 6, Issue 3, pp. e1290035, (2017) (PubMed).
-
-
